XPECT INDUSTRIAL EYE RELIEF- glycerin, naphazoline hcl solution/ drops 
Cintas Corporation

----------

Xpect Industrial Eye Relief 15mL (PLD)

Active ingredients

Glycerin 0.25%

Naphazoline HCl 0.012%

Purposes

Lubricant

Redness reliever

Uses

Warnings

For external use only

Do not use

if solution changes color or becomes cloudy

Ask a doctor before use if you have

narrow angle glaucoma

When using this product

  • to avoid contamination, do not touch tip of container to any surface
  • replace cap after using
  • overuse may produce increased redness of the eye
  • pupils may become enlarged temporarily

Stop use and ask a doctor if

  • you experience eye pain
  • you experience changes in vision
  • you experience continued redness or irritation of the eye
  • the condition worsens or persists for more than 72 hours

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

instill 1 to 2 drops in the affected eye(s) up to 4 times daily

Other information

store at room temperature

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

Questions?

1-877-973-2811

Monday-Friday

8:00am-5:00pm

Xpect Industrial Eye Relief 15mL

Xpect Industrial Eye Relief 15mL

XPECT INDUSTRIAL EYE RELIEF 
glycerin, naphazoline hcl solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:42961-255
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
NAPHAZOLINE HYDROCHLORIDE (UNII: MZ1131787D) (NAPHAZOLINE - UNII:H231GF11BV) NAPHAZOLINE HYDROCHLORIDE0.012 g  in 100 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN0.25 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42961-255-011 in 1 BOX09/18/2022
115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01803/01/2022
Labeler - Cintas Corporation (056481716)
Registrant - KC Pharmaceuticals, Inc. (174450460)
Establishment
NameAddressID/FEIBusiness Operations
KC Pharmaceuticals, Inc.174450460manufacture(42961-255) , pack(42961-255) , label(42961-255)

Revised: 12/2023
Document Id: 0d291a5f-b631-380c-e063-6394a90a0310
Set id: a0167d06-7adb-36f4-e053-2a95a90af9ef
Version: 4
Effective Time: 20231223
 
Cintas Corporation